|
SEC31A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.520300E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.332060E-02 |
| Normal-vs-Stage2 |
3.678800E-01 |
| Normal-vs-Stage3 |
2.661000E-03 |
| Normal-vs-Stage4 |
1.379620E-03 |
| Stage1-vs-Stage2 |
6.066600E-01 |
| Stage1-vs-Stage3 |
2.137800E-01 |
| Stage1-vs-Stage4 |
1.733400E-01 |
| Stage2-vs-Stage3 |
2.150600E-01 |
| Stage2-vs-Stage4 |
1.723820E-01 |
| Stage3-vs-Stage4 |
7.201000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.649500E-04 |
| Normal-vs-AfricanAmerican |
4.260000E-01 |
| Normal-vs-Asian |
8.364900E-03 |
| Caucasian-vs-AfricanAmerican |
2.391600E-01 |
| Caucasian-vs-Asian |
9.942400E-01 |
| AfricanAmerican-vs-Asian |
2.575800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.027250E-01 |
| Normal-vs-Female |
1.560810E-03 |
| Male-vs-Female |
2.284800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.322400E-02 |
| Normal-vs-Age(41-60Yrs) |
2.102800E-03 |
| Normal-vs-Age(61-80Yrs) |
1.955910E-03 |
| Normal-vs-Age(81-100Yrs) |
6.332000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.044400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.345420E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.620200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.966600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.572000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.286200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.794200E-01 |
| Classical-VS-Follicular |
1.087760E-02 |
| Classical-VS-Other |
8.203600E-01 |
| Classical-VS-Normal |
1.844820E-03 |
| Tall-VS-Follicular |
9.277900E-03 |
| Tall-VS-Other |
8.737800E-01 |
| Tall-VS-Normal |
3.777600E-03 |
| Follicular-VS-Other |
3.278000E-01 |
| Follicular-VS-Normal |
9.832600E-01 |
| Other-VS-Normal |
1.138610E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.295510E-02 |
| Normal-vs-N1 |
8.144000E-03 |
| N0-vs-N1 |
5.107800E-01 |
|
|
